Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

AACR 2015

18 - 22 Apr 2015
Pennsylvania Convention Center, Philadelphia, United States of America
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance
Dr Jonas Nilsson - Umeå University, Umeå, Sweden
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance ( Dr Jonas Nilsson - Umeå University, Umeå, Sweden )
13 May 2015
Comment: Metastatic triple-negative breast cancer responds to immunotherapy
Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA
Comment: Metastatic triple-negative breast cancer responds to immunotherapy ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )
1 May 2015
Real-world targeted treatment based on whole genome sequencing difficult in panc...
Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Aust...
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )
1 May 2015
Comment: Research developments stir hopes for melanoma
Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA
Comment: Research developments stir hopes for melanoma ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )
1 May 2015
Certain classes of genes in patients that could lead to prostate cancer
Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
Certain classes of genes in patients that could lead to prostate cancer ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
1 May 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant com...
Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negat...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
1 May 2015
Pembrolizumab found to be safe with durable responses in advanced non-small cell...
Dr Edward Garon - David Geffen School of Medicine at the University of Californi...
Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )
1 May 2015
PARP inhibitor combo shows early promise for patients with and without BRCA muta...
Dr Timothy Yap - Royal Marsden Hospital, London, UK
PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )
1 May 2015
Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanom...
Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
1 May 2015
Long-term, regular aspirin use modestly decreased cancer risk
Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Bo...
Long-term, regular aspirin use modestly decreased cancer risk ( Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Boston USA )
1 May 2015
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 May 2015
US breast cancer cases expected to increase by as much as 50 percent
Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Ca...
US breast cancer cases expected to increase by as much as 50 percent ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
1 May 2015
Investigational ER degrader safe, with early signs of antitumour activity agains...
Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA
Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer ( Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015
DNA stool test recommended as screening tool for colon cancer
Dr David Ahlquist - Mayo Clinic, Rochester, USA
DNA stool test recommended as screening tool for colon cancer ( Dr David Ahlquist - Mayo Clinic, Rochester, USA )
1 May 2015
How is ganetespib regulating the response of tumour cells in lung cancer?
Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
How is ganetespib regulating the response of tumour cells in lung cancer? ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
30 Apr 2015
New immunotherapy yields long-lasting responses in some patients with advanced m...
Dr Mark Middleton - University of Oxford, Oxford, UK
New immunotherapy yields long-lasting responses in some patients with advanced melanoma ( Dr Mark Middleton - University of Oxford, Oxford, UK )
30 Apr 2015
Extended overnight fasting may lead to reduced breast cancer risk
Dr Catherine Marinac - University of California, San Diego, USA
Extended overnight fasting may lead to reduced breast cancer risk ( Dr Catherine Marinac - University of California, San Diego, USA )
30 Apr 2015
Incidences of liver cancer rising in the USA
Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA
Incidences of liver cancer rising in the USA ( Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA )
30 Apr 2015
Black women found to have denser breast tissue than white women
Dr Anne Marie McCarthy - Massachusetts General Hospital, Boston, USA
Black women found to have denser breast tissue than white women ( Dr Anne Marie McCarthy - Massachusetts General Hospital, Boston, USA )
30 Apr 2015
What are the objectives for CART-meso immunotherapy?
Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA
What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )
30 Apr 2015
New data shows that generic drivers are found in benign conditions
Prof Razelle Kurzrock - University of California, San Diego, USA
New data shows that generic drivers are found in benign conditions ( Prof Razelle Kurzrock - University of California, San Diego, USA )
30 Apr 2015
How will genomics be applied to patient therapy in future?
Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant com...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Apr 2015
Investigational immunotherapy drug combo safe with early signs of effectiveness ...
Dr David Bajor - University of Pennsylvania, Philadelphia, USA
Investigational immunotherapy drug combo safe with early signs of effectiveness in advanced melanoma ( Dr David Bajor - University of Pennsylvania, Philadelphia, USA )
29 Apr 2015
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma
Dr Evan Alley - University of Pennsylvania, Philadelphia, USA
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma ( Dr Evan Alley - University of Pennsylvania, Philadelphia, USA )
29 Apr 2015
New approaches in computational pathology for risk assessment in benign breast d...
Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA
New approaches in computational pathology for risk assessment in benign breast diseases ( Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA )
29 Apr 2015
Chk1 inhibition combined with standard dose gemcitabine may be safe and effectiv...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Chk1 inhibition combined with standard dose gemcitabine may be safe and effective ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
29 Apr 2015
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negat...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
27 Apr 2015
US breast cancer cases expected to increase by as much as 50 percent by 2030
Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Ca...
US breast cancer cases expected to increase by as much as 50 percent by 2030 ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
27 Apr 2015
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
27 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant com...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2015
Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomar...
Dr Edward Garon - David Geffen School of Medicine at the University of Californi...
Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )
27 Apr 2015
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial
Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
27 Apr 2015